CA Patent

CA965411A — Method for the production of 2-substituted adenosine derivative

Assigned to Takeda Pharmaceutical Co Ltd · Expires 1975-04-01 · 51y expired

What this patent protects

Patent listed against regadenoson.

Drugs covered by this patent

Patent Metadata

Patent number
CA965411A
Jurisdiction
CA
Classification
—
Expires
1975-04-01
Drug substance claim
No
Drug product claim
No
Assignee
Takeda Pharmaceutical Co Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.